Arkolith/Insider Trading/IDYA/Form 4

Hata Yujiro S

President and CEO, DirectorIDEAYA Biosciences, Inc. (IDYA) · full profile →Form 4 · filed Feb 5, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$28K
Net Open-Market Flow
-$28K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 1, 2024Option exercise(M)628$4.31$3K679K
Feb 1, 2024Sell(S)4$45.01$180678K
Feb 1, 2024Sell(S)624$45.00$28K678K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 1, 2024Option exercise(M)628—$0324K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-24-000043) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML